TY - JOUR
T1 - H4K20me1 and H3K27me3 are concurrently loaded onto the inactive X chromosome but dispensable for inducing gene silencing
AU - Tjalsma, Sjoerd J.D.
AU - Hori, Mayako
AU - Sato, Yuko
AU - Bousard, Aurelie
AU - Ohi, Akito
AU - Raposo, Ana Cláudia
AU - Roensch, Julia
AU - Le Saux, Agnes
AU - Nogami, Jumpei
AU - Maehara, Kazumitsu
AU - Kujirai, Tomoya
AU - Handa, Tetsuya
AU - Bagés-Arnal, Sandra
AU - Ohkawa, Yasuyuki
AU - Kurumizaka, Hitoshi
AU - da Rocha, Simão Teixeira
AU - Żylicz, Jan J.
AU - Kimura, Hiroshi
AU - Heard, Edith
N1 - Funding Information:
We are grateful to members of the Heard Lab (Curie Institute and EMBL Heidelberg), especially Francois Dossin, and members of the Kimura Lab (Tokyo Tech) for their help and critical input to this project. We also want to thank the Bioimaging facility at iMM JLA for their technical support with fluorescent light microscopy and imaging analysis, and the Biomaterials Analysis Division, Open Facility Center, Tokyo Institute of Technology for DNA sequencing analysis. We thank Yolanda Markaki and Heinrich Leonhardt (LMU Munich) for sgRNA‐dCas9 plasmid constructs and Luke Lavis for JF646 dye. We thank Claus S. Sørensen for sharing H4K20me2 antibodies. This work was supported by Fundação para a Ciência e Tecnologia (S.T.d.R), project grants PTDC/BIA‐ MOL/29320/2017 IC&DT (A. C. R. & S.T.d.R), CEECUIND/01234/207 (S.T.d.R), and SFRH/BD/137099/2018 (A.C.R.), by an ERC Advanced Investigator award ERC‐ADG‐2014 671027 attributed to E.H., Sir Henry Wellcome Postdoctoral Fellowship (J.J.Z.), Japan Society for the Promotion of Science KAKENHI grants (JP17KK0143 and JP20K06484 to Y.S., JP19H04970, JP19H03158 and JP20H05393 to K.M., JP17K17719 to T.H., JP18H05534 to H.Ku, JP18H05527 and JP20H00456 to Y.O., JP17H01417 and JP18H05527 to H.Ki), and Japan Science and Technology Agency (JST) CREST JPMJCR16G1 to T.K., H.Ku, Y.O. and H.Ki, PREST JPMJPR2026 to K.M., and ERATO JPMJER1901 to H.Ku. J.J.Z. is supported by core funding of The Novo Nordisk Foundation Center for Stem Cell Biology (Novo Nordisk Foundation grant number NNF17CC0027852). Open Access funding enabled and organized by Projekt DEAL.
Funding Information:
We are grateful to members of the Heard Lab (Curie Institute and EMBL Heidelberg), especially Francois Dossin, and members of the Kimura Lab (Tokyo Tech) for their help and critical input to this project. We also want to thank the Bioimaging facility at iMM JLA for their technical support with fluorescent light microscopy and imaging analysis, and the Biomaterials Analysis Division, Open Facility Center, Tokyo Institute of Technology for DNA sequencing analysis. We thank Yolanda Markaki and Heinrich Leonhardt (LMU Munich) for sgRNA-dCas9 plasmid constructs and Luke Lavis for JF646 dye. We thank Claus S. Sørensen for sharing H4K20me2 antibodies. This work was supported by Fundação para a Ciência e Tecnologia (S.T.d.R), project grants PTDC/BIA- MOL/29320/2017 IC&DT (A. C. R. & S.T.d.R), CEECUIND/01234/207 (S.T.d.R), and SFRH/BD/137099/2018 (A.C.R.), by an ERC Advanced Investigator award ERC-ADG-2014 671027 attributed to E.H., Sir Henry Wellcome Postdoctoral Fellowship (J.J.Z.), Japan Society for the Promotion of Science KAKENHI grants (JP17KK0143 and JP20K06484 to Y.S., JP19H04970, JP19H03158 and JP20H05393 to K.M., JP17K17719 to T.H., JP18H05534 to H.Ku, JP18H05527 and JP20H00456 to Y.O., JP17H01417 and JP18H05527 to H.Ki), and Japan Science and Technology Agency (JST) CREST JPMJCR16G1 to T.K., H.Ku, Y.O. and H.Ki, PREST JPMJPR2026 to K.M., and ERATO JPMJER1901 to H.Ku. J.J.Z. is supported by core funding of The Novo Nordisk Foundation Center for Stem Cell Biology (Novo Nordisk Foundation grant number NNF17CC0027852). Open Access funding enabled and organized by Projekt DEAL.
Publisher Copyright:
© 2021 The Authors. Published under the terms of the CC BY 4.0 license
PY - 2021/3/3
Y1 - 2021/3/3
N2 - During X chromosome inactivation (XCI), in female placental mammals, gene silencing is initiated by the Xist long non-coding RNA. Xist accumulation at the X leads to enrichment of specific chromatin marks, including PRC2-dependent H3K27me3 and SETD8-dependent H4K20me1. However, the dynamics of this process in relation to Xist RNA accumulation remains unknown as is the involvement of H4K20me1 in initiating gene silencing. To follow XCI dynamics in living cells, we developed a genetically encoded, H3K27me3-specific intracellular antibody or H3K27me3-mintbody. By combining live-cell imaging of H3K27me3, H4K20me1, the X chromosome and Xist RNA, with ChIP-seq analysis we uncover concurrent accumulation of both marks during XCI, albeit with distinct genomic distributions. Furthermore, using a Xist B and C repeat mutant, which still shows gene silencing on the X but not H3K27me3 deposition, we also find a complete lack of H4K20me1 enrichment. This demonstrates that H4K20me1 is dispensable for the initiation of gene silencing, although it may have a role in the chromatin compaction that characterises facultative heterochromatin.
AB - During X chromosome inactivation (XCI), in female placental mammals, gene silencing is initiated by the Xist long non-coding RNA. Xist accumulation at the X leads to enrichment of specific chromatin marks, including PRC2-dependent H3K27me3 and SETD8-dependent H4K20me1. However, the dynamics of this process in relation to Xist RNA accumulation remains unknown as is the involvement of H4K20me1 in initiating gene silencing. To follow XCI dynamics in living cells, we developed a genetically encoded, H3K27me3-specific intracellular antibody or H3K27me3-mintbody. By combining live-cell imaging of H3K27me3, H4K20me1, the X chromosome and Xist RNA, with ChIP-seq analysis we uncover concurrent accumulation of both marks during XCI, albeit with distinct genomic distributions. Furthermore, using a Xist B and C repeat mutant, which still shows gene silencing on the X but not H3K27me3 deposition, we also find a complete lack of H4K20me1 enrichment. This demonstrates that H4K20me1 is dispensable for the initiation of gene silencing, although it may have a role in the chromatin compaction that characterises facultative heterochromatin.
UR - http://www.scopus.com/inward/record.url?scp=85101027909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101027909&partnerID=8YFLogxK
U2 - 10.15252/embr.202051989
DO - 10.15252/embr.202051989
M3 - Article
C2 - 33605056
AN - SCOPUS:85101027909
SN - 1469-221X
VL - 22
JO - EMBO Reports
JF - EMBO Reports
IS - 3
M1 - e51989
ER -